Reuters logo
BRIEF-Zhejiang Huahai Pharmaceutical passes FDA approval
September 28, 2017 / 3:07 AM / 23 days ago

BRIEF-Zhejiang Huahai Pharmaceutical passes FDA approval

Sept 28 (Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd

* Says it received approval for its production base of API from U.S Food and Drug Administration

Source text in Chinese:goo.gl/S41WCf

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below